(Q39197615)

9 September 2017

title

Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro (English)

1 reference

9 September 2017

main subject

Plasmodium falciparum

0 references

0 references

1 reference

Walther H Wernsdorfer

6

object named as

Walther H Wernsdorfer

1 reference

Jeeraphat Sirichaisinthop

9 September 2017

4

object named as

Jeeraphat Sirichaisinthop

1 reference

9 September 2017

3

Gunther Wernsdorfer

1 reference

Chaiporn Rojanawatsirivet

9 September 2017

2

object named as

Chaiporn Rojanawatsirivet

1 reference

9 September 2017

Carola Lütgendorf

1

1 reference

9 September 2017

Herwig Kollaritsch

5

1 reference

9 September 2017

publication date

1 January 2006

1 reference

9 September 2017

published in

Vienna Clinical Weekly

1 reference

9 September 2017

volume

118

1 reference

9 September 2017

issue

19-20 Suppl 3

1 reference

9 September 2017

page(s)

70-76

1 reference

A Method for Testing for Synergy with Any Number of Agents

9 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00508-006-0685-Z

Malarone treatment failure not associated with previously described mutations in the cytochrome b gene

21 January 2018

1 reference

12 December 2020

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

1 reference

12 December 2020

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS

1 reference

12 December 2020

Atovaquone/proguanil resistance in Africa: a case report.

1 reference

12 December 2020

Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate

1 reference

12 December 2020

Malaria at the turn from the 2nd to the 3rd millenium.

1 reference

12 December 2020

Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.

1 reference

12 December 2020

Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10.

1 reference

12 December 2020

Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro

1 reference

12 December 2020

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil

1 reference

12 December 2020

Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group

1 reference

12 December 2020

Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity

1 reference

12 December 2020

A simplified method of evaluating dose-effect experiments

1 reference

12 December 2020

Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique

1 reference

12 December 2020

Field evaluation of drug resistance in malaria. In vitro micro-test

1 reference

12 December 2020

10.1007/S00508-006-0685-Z

Identifiers

DOI

1 reference

release_laa7u3zufvasjd46gw5cpejf5a

9 September 2017

Fatcat ID

0 references

1 reference